Table 1.
Baseline characteristics of the participants in terms of disease state.
| Patients with stage I-II HFMD (n=104) | Patients with stage III-IV HFMD (n=18) | Controls (n=40) | p-value | |
|---|---|---|---|---|
| Age (years) | 1.83 (1.31, 2) | 1.87 (1.21, 2.75) | 6 (4, 8.25) | <10-4 |
| Gender (male/female) | 76/28 | 15/3 | 20/20 | 0.01 |
| WBC count (109/L) | 11.29 (9.43, 14.57) | 12.95 (10.71, 17.92) | 8.75 (6.95, 10.98) | 0.001 |
| HB level (g/L) | 119.5 (114, 123) | 118 (109, 125) | -- | 0.86 |
| PLT count (109/L) | 261.23±77.02 | 309.06±74.49 | 283.75±55.86 | 0.044 |
| ALT level (u/L) | 16 (12, 21) | 14.5 (12, 19.5) | -- | 0.046 |
| AST level (u/L) | 31 (26, 41) | 27 (25, 38) | -- | 0.14 |
| ALB level (g/L) | 45.6 (43.2, 47.7) | 45.75 (43.58, 48.83) | -- | 0.99 |
| Scr level (umol/L) | 21.45 (17.38, 24.9) | 20 (17.8, 22.8) | -- | 0.53 |
| Ca level (mmol/L) | 2.48±0.10 | 2.46±0.13 | -- | 0.39 |
| P level (mmol/L) | 1.76±0.21 | 1.75±0.22 | -- | 0.79 |
| Mg level (mmol/L) | 0.90±0.09 | 0.85±0.08 | -- | 0.024 |
HFMD: hand, foot, and mouth disease, WBC: white blood cell, HB: hemoglobulin, PLT: platelet, ALT: alanine aminotransferase, AST: aspartate aminotransferase, ALB: albumin, Scr: serum creatinine, Ca: calcium, P: phosphorus, Mg: magnesium.